Mikael Sodergren MBChB, DIC, PhD, FRCS is a Senior Clinical Lecturer at Imperial College London and Consultant Hepatobiliary & Pancreatic Surgeon at Imperial College Healthcare NHS Trust.
His clinical interests include complex pancreas, liver & gallbladder cancer surgery as well as laparoscopic & robotic approaches. He was part of the team that pioneered and carried out the first cases of natural orifice translumenal endoscopic surgery (NOTES) in the UK.
His research portfolio is based on novel technological innovation & therapeutics with the following major themes:
1) Therapies related to immuno-oncology in liver and pancreas cancer using saRNA and aptamer technologies
2) Methods of immunomodulation in cancer with focus on radiofrequency ablation
4) Brain-computer interfacing with an emphasis on eye tracking technology
5) Cannabis-based medicinal products - he is currently leading a broad research programme from pre-clinical to clinical studies focusing on pain, inflammation and cancer
et al., 2020, Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma, Surgical Oncology-oxford, Vol:35, ISSN:0960-7404, Pages:211-217
et al., 2020, Comparison of surgeon gaze behaviour against objective skill assessment in laparoscopic cholecystectomy-a prospective cohort study, International Journal of Surgery, Vol:82, ISSN:1743-9159, Pages:149-155
et al., 2020, No difference in mortality among ALPPS, two-staged hepatectomy, and portal vein embolization/ligation: A systematic review by updated traditional and network meta-analyses, Hepatobiliary & Pancreatic Diseases International, Vol:19, ISSN:1499-3872, Pages:411-419
et al., 2020, Cannflavins - From plant to patient: A scoping review., Fitoterapia, Vol:146, ISSN:0367-326X, Pages:1-10
et al., 2020, Visual gaze patterns reveal surgeons' ability to identify risk of bile duct injury during laparoscopic cholecystectomy, Hpb, ISSN:1365-182X